Delivery Order SPE2DB25D3020-SPE2DB26FWGAA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) valued at $3,359.77, with an ultimate completion date of September 11, 2025. This competitive award, issued September 10, 2025, utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,549.80 on July 29, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 30, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $17,446.83 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract with an ultimate completion date of August 19, 2025. This non-set-aside delivery order represents a single procurement action drawn from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency Medical Supply Chain awarded a $57,770.08 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Multaq 400 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, with performance based in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract valued at $8,801.10. The order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $3,697.14 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, which is a non-set-aside competitive award, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. Performance will take place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $25,511.16 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 13, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Multaq 400 mg tablets (60-count packages) valued at $11,622.61. This competitively awarded, firm fixed-price delivery order is set to be completed by October 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $3,418.56 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on October 15, 2025, with completion scheduled for October 16, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $16,683.12 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on June 4, 2025, with completion scheduled for June 5, 2025. This competitive award, issued without set-aside designation, utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB26FWGAADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract valued at $4,239.14. The order was competitively awarded without set-aside designation and carries an ultimate completion date of November 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The Multaq supply supports the Defense Health Agency's pharmaceutical procurement needs within the military healthcare system. AmerisourceBergen's substantial IDC vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. The contractor's demonstrated capability in federal medical procurement, evidenced by its consistent receipt of competitively awarded contracts across multiple therapeutic domains, positions it as a critical vendor within the DLA Medical Supply Chain serving military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/3/25 |